Providing market intelligence for more than 35 years

In The News

mHealth Still Missing the Comfort Zone for Chronic Care Patients

A report from digital health analyst Parks Associates indicates 27 percent of those surveyed with a chronic condition want a mobile health device that tracks their condition – yet significant numbers also report that the devices they now have are too complicated to use or don’t work properly.

"Nearly one-half of type I diabetics and one-third of type II diabetics are interested in health monitoring devices such as glucometers, but a steep learning curve and difficult or counterintuitive directions could inhibit their usage of these devices and also prevent them from buying other connected health devices," Harry Wang, the group’s senior director of research, said in a press release accompanying the report. "Device and application manufacturers would benefit from improving the ease-of-use of these devices."

The study points to a continuation of missed opportunities in mHealth for both patients and their caregivers. 

From the article "mHealth Still Missing the Comfort Zone for Chronic Care Patients" by Eric Wicklund.

Previously In The News

Report: Connected Home Consumers Want Data Security Support

Several recent studies have shown that security and privacy are top of mind for consumers considering Internet of Things devices for their homes. Parks Associates back in October noted around 40 pe...

12% of Canadian broadband households have smart home device

Approximately 12 percent of broadband households in Canada have a smart home device such as a smart thermostat, smart door look, or video doorbell, compared to 26 percent in the US, according to data...

Western European Smart Thermostat Sales To Hit 1 Mln By 2020

Sales of smart thermostats in Western Europe are set to rise from less than 700,000 units in 2016 to more than one million units by 2020, according to a report on smart energy and water products by Pa...

The Simple Reason Why I Won't Buy Roku Inc.

Roku (NASDAQ:ROKU) went public on Sep. 28, its stock surging nearly 70% from its IPO price of $14 per share. The stock hit almost $30 the following day, but subsequently pulled back to the low $20s....